https://www.selleckchem.com/products/sel120.html
g. benign) samples, and obtained sensitivity and specificity of 0.92 and 1, respectively; this surpasses other works. We also introduce a novel approach, using 5-class models (i.e. normal, benign, cancer-metastatic-non/low/high) that provided average sensitivity and specificity of 0.69 and 0.91. Combining our rapid, mechanical invasiveness assay with machine learning classification can provide accurate and early prognosis of metastatic risk, to support choice of treatments and disease management.This research was performed to examine the
إعجاب
علق
شارك
Palak Nayyar
https://support.us.edu/hc/en-u....s/community/posts/26
https://support.empowersuite.c....om/hc/en-us/communit
https://support.empowersuite.c....om/hc/en-us/communit
https://support.empowersuite.c....om/hc/en-us/communit
https://support.us.edu/hc/en-u....s/community/posts/26
https://support.us.edu/hc/en-u....s/community/posts/26
حذف التعليق
هل أنت متاكد من حذف هذا التعليق ؟